Dr.REYNA-VANGILDER | Society of Life Sciences (SoLS)

A Journal of Postdoctoral Research.

Login | Register

Jobs

Article

Authors

ISSN : 2328-9791

Hall of Fame

EDITORIAL BOARD

Dr. REYNA VANGILDER

Address 1	:
Address 2	:
Title	:	Dr.
First Name	:	REYNA
Last Name	:	VANGILDER
University/Institution	:	West Virginia University
Phone #	:	304-293-
Email ID	:	rvangilder@mix.wvu.edu
City	:	Morgantown
Country	:	United States
State	:	West virginia
Zipcode	:	26505

Department	:	School of Pharmacy
Company Name	:
Area of Research
Translational Brain Injury Research

Brief Description of Research Interest :
Dr. VanGilder applies a multidisciplinary perspective to understanding the pathology of human disease and is interested in how peripheral biomarkers can be used to monitor disease risk/ progression and stratify pharmacological and biological therapies for brain related diseases. With a basic sciences in blood brain barrier pathology and clinical research training specializing in peripheral biomarkers of brain injury, Dr. VanGilder possesses a translational approach to understanding how molecular pathologies mediated through inflammatory pathways can potentially mediate outcomes in co-morbid disease states. To further enhance this understanding of therapeutic interventions, Dr. VanGilder is currently enrolled in the doctor of pharmacy program at West Virginia University. In addition, Dr. VanGilder has a strong interest in translating scientific communication by helping basic scientists better communicate the significance of research findings to a general audience and helping medical professional students better understand molecular pathology as it relates to human disease.
Representative Publications :
VanGilder RL, Davidov DM, Steinhart KR, Huber JD, Turner RC, WilsonKS, Haney E, Davis SM, Chantler PD, Theekie LA Rosen CL, Crocco TJ, Gutmann L, BarrTL: C-Reactive Protein and Long-Term Ischemic Stroke Prognosis. J. ClinNeurosci. (2013). doi:10.1136/neurintsurg-2013-010780. VanGilder RL, Rosen CL, Huber JD, BarrTL: Transcriptome of Ischemic Stroke: Brain Res Bull. Brain Res Bull. (2012). 88(4):313-19. VanGilder RL, Rosen CL, Barr TL, Huber JD: Targeting the neurovascular unit fortreatment of neurological disorders. Pharmacol.Ther. (2011). 130(3):239-47. VanGilder RL, Kelly KA, Chua MD, Ptachinski RL, Huber JD:Administration of sesamol improved blood-brain barrier function instreptozotocin-induced diabetic rats. Exp Brain Res. (2009). 197(1):23-24. Brooks SD, Spears C, Cummings C, VanGilder RL, Stinehart KR, Gutmann L, Domico J, Culp S, Carpenter J, Rai A, Barr TL: Admission Neutrophil-Lymphocyte Ratio predicts 90 Day Outcome after Endovascular Stroke Therapy. J NeuroInterv Surg. (2013). doi: 10.1136/neurintsurg-2013-010780. Huber JD, VanGilderRL, Houser KA: Streptozotocin-induced diabetes progressively increasesblood-brain barrier permeability in specific brain regions in rats. Am J Physiol. (2006). 291:2660-8.
Resume	:	Download

Madireddy Lab

Genetics Society of America

American Society for Biochemistry and Molecular Biology

Postdoc of the Month Application Information

Postdoc Proceedings : Call for Abstracts

About Us

Blog

Contact Us

FAQ's

Privacy Policy

T&C

Disclaimer

Instructions For Authors

Site Map

Sponsor

STAY CONNECTED

3304 Sawtooth Ct., Westlake Village, CA 91362 USA

(818)917-1274

info@postdocjournal.com

PDJ © 2012

AmkaysWeb

Click Here